{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:40:22Z","timestamp":1778236822981,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of Health, Section for the Monitoring and Control of Doping and the Protection of Health in Sports Activities","award":["J52I14001600005"],"award-info":[{"award-number":["J52I14001600005"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jpba.2018.01.043","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T12:21:44Z","timestamp":1517401304000},"page":"204-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches"],"prefix":"10.1016","volume":"152","author":[{"given":"Michele","family":"Protti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carmen","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boaz Gedaliahu","family":"Samolsky Dekel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Rudge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"Gerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Somaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Mandrioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mercolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2018.01.043_bib0005","first-page":"55","article-title":"The laboratory\u2019s role in opioid pain medication monitoring","volume":"23","author":"Bodor","year":"2012","journal-title":"EJIFCC"},{"key":"10.1016\/j.jpba.2018.01.043_bib0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/ACO.0b013e32832bc818","article-title":"Oxycodone: new \u2018old\u2019 drug","volume":"22","author":"Olkkola","year":"2009","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.jpba.2018.01.043_bib0015","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1592\/phco.22.11.898.33628","article-title":"Safety and efficacy of controlled-release oxycodone: a systematic literature review","volume":"22","author":"Rischitelli","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpba.2018.01.043_bib0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites","volume":"79","author":"Lalovic","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2018.01.043_bib0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1124\/dmd.32.4.447","article-title":"Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes","volume":"32","author":"Lalovic","year":"2004","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.jpba.2018.01.043_bib0030","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","volume":"5","author":"Nielsen","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpba.2018.01.043_bib0035","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2217\/pgs.09.64","article-title":"Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management","volume":"10","author":"Jannetto","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jpba.2018.01.043_bib0040","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/papr.12483","article-title":"Dialyzability of oxycodone and its metabolites in chronic noncancer pain patients with end-stage renal disease","volume":"17","author":"Samolsky Dekel","year":"2017","journal-title":"Pain Pract."},{"key":"10.1016\/j.jpba.2018.01.043_bib0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamapsychiatry.2017.0113","article-title":"Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001\u20132002 to 2012\u20132013 national epidemiologic survey on alcohol and related conditions","volume":"74","author":"Martins","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpba.2018.01.043_bib0050","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1377\/hlthaff.2015.1496","article-title":"Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates","volume":"35","author":"Patrick","year":"2016","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.jpba.2018.01.043_bib0055","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.4155\/bio.15.123","article-title":"Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs","volume":"7","author":"Mercolini","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2018.01.043_bib0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpba.2016.06.046","article-title":"Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis","volume":"130","author":"Mercolini","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.01.043_bib0065","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1007\/s00216-015-9051-1","article-title":"Analysis of \u03b3-hydroxy butyrate by combining capillary electrophoresis-indirect detection and wall dynamic coating: application to dried matrices","volume":"407","author":"Saracino","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2018.01.043_bib0070","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2018.01.043_bib0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jchromb.2016.12.038","article-title":"Dried haematic microsamples and LC\u2013MS\/MS for the analysis of natural and synthetic cannabinoids","volume":"1044\u20131045","author":"Protti","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2018.01.043_bib0080","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpba.2016.02.015","article-title":"LC\u2013MS\/MS and volumetric absorptive microsampling for quantitative bioanalysis of cathinone analogues in dried urine, plasma and oral fluid samples","volume":"123","author":"Mercolini","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.01.043_bib0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/dta.1927","article-title":"Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on-line SPE-LC\u2013MS\/MS","volume":"8","author":"Verplaetse","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2018.01.043_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2015.06.028","article-title":"Development of a new multi-analyte assay for the simultaneous detection of opioids in serum and other body fluids using liquid chromatography-tandem mass spectrometry","volume":"1001","author":"Eckart","year":"2015","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2018.01.043_bib0095","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.4155\/bio.15.157","article-title":"Validation of a fast UPLC-MS\/MS method for quantitative analysis of opioids cocaine, amphetamines (and their derivatives) in human whole blood","volume":"7","author":"Feliu","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2018.01.043_bib0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.forsciint.2014.08.022","article-title":"Method development and validation for simultaneous quantification of 15 drugs of abuse and prescription drugs and 7 of their metabolites in whole blood relevant in the context of driving under the influence of drugs\u2013usefulness of multi-analyte calibration","volume":"244","author":"Steuer","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2018.01.043_bib0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2014.0191","article-title":"Monitoring oxycodone use in patients with chronic pain: analysis of oxycodone and metabolite excretion in saliva and urine","volume":"10","author":"Moy","year":"2014","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.jpba.2018.01.043_bib0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jat\/bku024","article-title":"Validation of an automated solid-phase extraction method for the analysis of 23 opioids, cocaine, and metabolites in urine with ultra-performance liquid chromatography-tandem mass spectrometry","volume":"38","author":"Fernandez","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2018.01.043_bib0115","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/bmc.2945","article-title":"Rapid and simultaneous determination of multiple classes of abused drugs and metabolites in human urine by a robust LC\u2013MS\/MS method \u2013 application to urine drug testing in pain clinics","volume":"27","author":"Wang","year":"2013","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2018.01.043_bib0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/cclm.2011.739","article-title":"Simultaneous quantification of 19 drugs\/metabolites in urine important for pain management by liquid chromatography-tandem mass spectrometry","volume":"50","author":"Yuan","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jpba.2018.01.043_bib0125","series-title":"Using UHPLC\/MS (TOF) for Detection of Drugs and Metabolites in Urine Following Optimized Enzymatic Hydrolysis Conditions, Reporter US 33.2","first-page":"20","author":"Aurand","year":"2015"},{"key":"10.1016\/j.jpba.2018.01.043_bib0130","series-title":"Guideline on Bioanalytical Method Validation","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.jpba.2018.01.043_bib0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jchromb.2008.04.003","article-title":"Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry","volume":"867","author":"ter Heine","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2018.01.043_bib0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpba.2014.02.005","article-title":"Multi-matrix assay of the first melatonergic antidepressant agomelatine by combined liquid chromatography-fluorimetric detection and microextraction by packed sorbent","volume":"95","author":"Saracino","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.01.043_bib0145","first-page":"49","article-title":"Comparison of the determination of drugs with influence on driving performance in serum, whole blood and dried blood spots","volume":"80","author":"Jantos","year":"2013","journal-title":"Toxichem Krimtech"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517331345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517331345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T10:54:08Z","timestamp":1535108048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517331345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":29,"alternative-id":["S0731708517331345"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.01.043","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}